期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma 被引量:50
1
作者 wei wang~1 shu-kui qin~1 bao-an chen~2 hui-ying chen~1 1 chinese pla cancer center,chinese pla 81 hospital,nanjing 210002,jiangshu province,china2 affliliated zhongda hospital of southeast university medical college,nanjing 210087,jiangsu province,china 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第5期702-705,共4页
INTRODUCTIONThe main component of a traditional Chinese drug 'Pishuang'. arsenic trioxide (As2O3), has obviously selective anti-tumor effect on human hepatocellular carcinoma (HCC)in both in vitro and in vivo ... INTRODUCTIONThe main component of a traditional Chinese drug 'Pishuang'. arsenic trioxide (As2O3), has obviously selective anti-tumor effect on human hepatocellular carcinoma (HCC)in both in vitro and in vivo studies[1-5]. Due to limited effectiveness when any anti-carcinogen is used alone and obviously increased toxicity when the dose is raised, there is no exception for As2O3. Furthermore, combined chemotherapy contributes to improve therapeutic effectiveness, disperse toxicity and surmount drug-resistance,in which the combination of traditional Chinese and modern medicine has more advantages and characteristics. As a result,we made an experimental study on anti-tumor effect of As2O3in combination with cisplantin (PDD) or doxorubicin (ADM)on HCC. to investigate the possibility of AS2O3 in combination with PDD or ADM and nature of interaction between them,and to provide experimental basis for clinical application. 展开更多
关键词 liver neoplasms carcinoma hepatocellular MINOR cells cultured/drug effects arsenicals/pharmacology cisplatin/pharmacology doxorubicin/pharmacology
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部